Brief: Ziccum Signs Evaluation Agreement For Feasibility Study

Ziccum AB

17/07/2023 14:04

July 17 (Reuters) - Ziccum AB  ZICC.ST :
    * ZICCUM SIGNS EVALUATION AGREEMENT FOR FEASIBILITY STUDY
WITH
MAJOR GLOBAL PHARMACEUTICAL CORPORATION
    * AGREEMENT IS TO PERFORM A FUNDED FEASIBILITY STUDY AIMING
TO
DEVELOP THERMOSTABLE DRY POWDER FORMULATIONS IN PARTNER MRNA/LNP
PROJECTS
    * AGREEMENT HAS A PLANNED EXTENSION FOR STABILITY TESTING
AND AN
OPTION TO LICENSE LAMINARPACE TECHNOLOGY
    * CURRENT PROJECT IS EXPECTED TO COMMENCE IN JULY 2023 AND
FIRST
STAGE WILL RUN FOR A NUMBER OF MONTHS

Source text for Eikon:  ID:nMFN8hS5pt 
Further company coverage:  ZICC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))